Qube Research & Technologies (QRT)’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.3K Sell
3,041
-1,357
-31% -$19.5K ﹤0.01% 3383
2026
Q2
$60.9K Sell
4,398
-3,541
-45% -$54.1K ﹤0.01% 3096
2026
Q1
$141K Sell
7,939
-3,252
-29% -$79.8K ﹤0.01% 3016
2025
Q4
$311K Buy
11,191
+5,953
+114% +$172K ﹤0.01% 2939
2025
Q3
$208K Buy
+5,238
New +$213K ﹤0.01% 2937
2024
Q1
– Sell
-8,012
Closed -$498K – 4836
2023
Q4
$498K Buy
8,012
+6,895
+617% +$517K ﹤0.01% 2288
2023
Q3
$134K Sell
1,117
-4,725
-81% -$664K ﹤0.01% 2558
2023
Q2
$978K Buy
5,842
+2,801
+92% +$582K ﹤0.01% 1307
2023
Q1
$768K Sell
3,041
-6,957
-70% -$1.61M ﹤0.01% 1400
2022
Q4
$1.82M Buy
+9,998
New +$2.16M 0.01% 977

Other funds holding SKIN

Qube Research & Technologies (QRT)'s SKIN Position: Q3 2026 in Review

Qube Research & Technologies (QRT) reduced its SkinHealth Systems (SKIN) stake by 31% in Q3 2026, selling an estimated $19.5K and leaving 3,041 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.

Qube Research & Technologies (QRT) first reported a position in SKIN in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.82M in Q4 2022. 70 funds tracked by Wall St. Rank hold SKIN as of Q3 2026.

  • Qube Research & Technologies (QRT) held 3,041 shares of SkinHealth Systems worth $38.3K as of Q3 2026.
  • Qube Research & Technologies (QRT) sold 1,357 SkinHealth Systems shares in Q3 2026, an estimated $19.5K.
  • SkinHealth Systems made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #3383 holding.
  • Qube Research & Technologies (QRT) first reported a position in SkinHealth Systems in Q4 2022 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s SkinHealth Systems position peaked at $1.82M in Q4 2022.
  • 70 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.